Radioiodine Treatment Characteristics
| Characteristic | No. of patients | Median | IQR |
| No. of 131I treatments | 1 | 1–3 | |
| Cumulative 131I activity per 131I treatment (GBq) | |||
| Only ablation | 34 (52.3%) | 3.7 | 1.85–5.85 |
| Repeated | 31 (47.7%) | 12.95 | 7.92–18.50 |
| 2 | 13 (20.0%) | 5.55 | 3.70–5.81 |
| 3 | 7 (10.8%) | 5.55 | 3.70–5.70 |
| 4 | 4 (6.2%) | 5.55 | 3.70–5.62 |
| 5 | 5 (7.7%) | 6.11 | 5.55–7.59 |
| 6 | 2 (3.1%) | 6.44* | |
| Cumulative 131I activity of all patients (GBq) | 65 (100%) | 5.88 | 2.92–12.95 |
| Cumulative 131I activity (GBq) per TNM stage | |||
| Stage I | 52 (80%) | 5.71 | 2.78–11.75 |
| Stage II | 6 (9.2%) | 14.43 | 11.24–19.14 |
| Stage unknown | 7 (10.8%) | 5.71 | 2.18–8.33 |
↵* IQR could not be estimated.